Jinhai Medical Technology Ltd. Reports Interim Revenue Increase to S$14,529,000 for H1 2025, Up from S$12,302,000 in 2024

Reuters09-23

Jinhai Medical Technology Ltd. Reports Interim Revenue Increase to S$14,529,000 for H1 2025, Up from S$12,302,000 in 2024

Jinhai Medical Technology Ltd. has released its interim report for 2025, highlighting significant financial results for the period ending June 30. The company reported a total revenue of S$14.5 million for the first half of 2025, compared to S$25.9 million in the same period of the previous year. This indicates a decrease of S$11.4 million in revenue year-on-year. The net loss for the period attributable to the owners of the company was reported at S$10.3 million, an increase from the S$6.0 million net loss reported for the same period in 2024. This increase in net loss reflects a challenging financial period for the company. Earnings per share were not reported as they were negative for this period. There is no specific outlook or guidance provided in the interim report for the future financial periods. The report does not include any significant updates regarding business operations beyond the reported financials.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jinhai Medical Technology Ltd. published the original content used to generate this news brief on September 23, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2569765521?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-23 12:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2569765521","market":"nz","top_or_hot":-1,"title":"Jinhai Medical Technology Ltd. Reports Interim Revenue Increase to S$14,529,000 for H1 2025, Up from S$12,302,000 in 2024","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Jinhai Medical Technology Ltd. Reports Interim Revenue Increase to S$14,529,000 for H1 2025, Up from S$12,302,000 in 2024\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Jinhai Medical Technology Ltd. has released its interim report for 2025, highlighting significant financial results for the period ending June 30. The company reported a total revenue of S$14.5 million for the first half of 2025, compared to S$25.9 million in the same period of the previous year. This indicates a decrease of S$11.4 million in revenue year-on-year. The net loss for the period attributable to the owners of the company was reported at S$10.3 million, an increase from the S$6.0 million net loss reported for the same period in 2024. This increase in net loss reflects a challenging financial period for the company. Earnings per share were not reported as they were negative for this period. There is no specific outlook or guidance provided in the interim report for the future financial periods. The report does not include any significant updates regarding business operations beyond the reported financials.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jinhai Medical Technology Ltd. published the original content used to generate this news brief on September 23, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jinhai Medical Technology Ltd. Reports Interim Revenue Increase to S$14,529,000 for H1 2025, Up from S$12,302,000 in 2024</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJinhai Medical Technology Ltd. Reports Interim Revenue Increase to S$14,529,000 for H1 2025, Up from S$12,302,000 in 2024\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-23 12:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Jinhai Medical Technology Ltd. Reports Interim Revenue Increase to S$14,529,000 for H1 2025, Up from S$12,302,000 in 2024\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Jinhai Medical Technology Ltd. has released its interim report for 2025, highlighting significant financial results for the period ending June 30. The company reported a total revenue of S$14.5 million for the first half of 2025, compared to S$25.9 million in the same period of the previous year. This indicates a decrease of S$11.4 million in revenue year-on-year. The net loss for the period attributable to the owners of the company was reported at S$10.3 million, an increase from the S$6.0 million net loss reported for the same period in 2024. This increase in net loss reflects a challenging financial period for the company. Earnings per share were not reported as they were negative for this period. There is no specific outlook or guidance provided in the interim report for the future financial periods. The report does not include any significant updates regarding business operations beyond the reported financials.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jinhai Medical Technology Ltd. published the original content used to generate this news brief on September 23, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02225","symbol_name":"今海医疗科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nNDLDL68l:1","article_id":"2569765521","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2569765521","pubTimestamp":1758600615,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Jinhai Medical Technology Ltd. has released its interim report for 2025, highlighting significant financial results for the period ending June 30. The company reported a total revenue of S$14.5 million for the first half of 2025, compared to S$25.9 million in the same period of the previous year. This indicates a decrease of S$11.4 million in revenue year-on-year. The net loss for the period attributable to the owners of the company was reported at S$10.3 million, an increase from the S$6.0 million net loss reported for the same period in 2024. This increase in net loss reflects a challenging financial period for the company. Earnings per share were not reported as they were negative for this period. There is no specific outlook or guidance provided in the interim report for the future financial periods. The report does not include any significant updates regarding business operations beyond the reported financials.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02225":"今海医疗科技","BK1150":"人力资源与就业服务"},"translate_title":"金海医疗科技有限公司报告称，2025年上半年中期收入从2024年的12,302,000新元增至14,529,000新元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02225":0.9},"content_text":"Jinhai Medical Technology Ltd. Reports Interim Revenue Increase to S$14,529,000 for H1 2025, Up from S$12,302,000 in 2024\n    \n\n        Jinhai Medical Technology Ltd. has released its interim report for 2025, highlighting significant financial results for the period ending June 30. The company reported a total revenue of S$14.5 million for the first half of 2025, compared to S$25.9 million in the same period of the previous year. This indicates a decrease of S$11.4 million in revenue year-on-year. The net loss for the period attributable to the owners of the company was reported at S$10.3 million, an increase from the S$6.0 million net loss reported for the same period in 2024. This increase in net loss reflects a challenging financial period for the company. Earnings per share were not reported as they were negative for this period. There is no specific outlook or guidance provided in the interim report for the future financial periods. The report does not include any significant updates regarding business operations beyond the reported financials.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jinhai Medical Technology Ltd. published the original content used to generate this news brief on September 23, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2569765521","isCrawlerRequest":true}